Non-White Patients Assigned Less Severe Triage Scores
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
MONDAY, Oct. 16, 2023 -- Mistriage of non-White patients in the emergency department appears to be common, according to a study published online Oct. 12 in JAMA Network Open.
Joshua W. Joseph, M.D., from Brigham and Women's Hospital in Boston, and colleagues examined whether racial disparities in triage scores and physician evaluations are present across a multicenter network of academic and community hospitals and whether patients who do not speak English face similar disparities. The analysis included 249,829 visits at seven emergency departments for one of five common complaints.
The researchers found that White patients had significantly more acute Triage Emergency Severity Index scores than Hispanic patients or patients self-identified as Other race and ethnicity across all symptoms (e.g., chest pain: Hispanic, 2.68; White, 2.55; Other, 2.66) and Black patients across most symptoms (e.g., nausea/vomiting: Black, 2.97; White, 2.90). A significant reversal of these differences was seen for visit work relative value units (e.g., chest pain: Black, 4.32; Hispanic, 4.13; White, 3.55; Other, 3.96). For patients whose primary language was not English, similar patterns were observed.
"These findings suggest the need to address systemic disparities in the emergency department triage process," the authors write. "Clinical decision support systems might reduce these disparities but would require careful calibration to avoid replicating bias."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.